Despite unprecedented efforts to develop COVID-19 vaccines in record time amid the global pandemic, SARS-CoV-2 continues to spread rapidly with the emergence of new variants, such as Delta and Omicron, making the development ...
Jan 13, 2022
0
78
COVID-19 has nothing on tuberculosis. The bacterial infection has ravaged humanity for thousands of years—accounting for one quarter of all deaths in the United States and Europe for 300 years before the discovery of antibiotics.
Dec 22, 2021
0
2
Mycobacterium tuberculosis (Mtb), the hardy bacterial species that causes tuberculosis (TB), has an unexpected vulnerability that future drugs may be able to exploit, according to a study from researchers at Weill Cornell ...
Dec 21, 2021
0
58
A long, long time ago, the BCG vaccine was approved for use against tuberculosis (TB), and it's still given to infants today. For generations, the vaccine has saved lives and prevented untold suffering. And yet TB still kills ...
Dec 13, 2021
0
225
A new all-oral six-month treatment regimen is safer and more effective at treating rifampicin-resistant tuberculosis (RR-TB) than the current accepted standard of care, according to results announced at the 52nd Union World ...
Oct 20, 2021
0
5
Breathing is enough to spread the bacteria that causes tuberculosis, research presented at a major conference on Tuesday shows, potentially forcing the medical community to rethink decades of containment strategy focusing ...
Oct 19, 2021
0
51
Using cutting-edge genomic sequencing techniques, researchers at the University of Oxford have identified almost all the genomic variation that gives people resistance to 13 of the most common tuberculosis (TB) drug treatments.
Oct 19, 2021
0
1
Tuberculosis is on the rise again globally for the first time in a decade, linked to disruptions in access to healthcare because of the COVID pandemic, the World Health Orgnization said on Thursday.
Oct 14, 2021
0
6
Young people are at risk of falling seriously unwell with tuberculosis and spreading the disease. Therefore, researchers at Karolinska Institutet in Sweden, among others, have mapped key factors that affect the treatment ...
Sep 14, 2021
0
16
(HealthDay)—Tuberculosis preventive treatment completion is higher with three months of rifapentine-isoniazid than six months of isoniazid among patients with HIV receiving antiretroviral therapy, according to a study published ...
Aug 24, 2021
0
37
